Clinical Trial Update: HCMV Breakthrough Infections During Letermovir Prophylaxis [NA]

View source ↗

Summary

Clinical trial update reporting breakthrough cytomegalovirus infections occurring despite letermovir prophylaxis in hematopoietic stem cell transplant recipient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Cytomegalovirus Viremia

Drugs mentioned

• Letermovir (Prevymis) (letermovir)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Cytomegalovirus Infections, Cytomegalovirus Viremia | NA | Status: UNKNOWN